(Q37122595)

18 August 2017

Usefulness of anti-ulcer drugs for the prevention and treatment of peptic ulcers induced by low doses of aspirin (English)

1 reference

18 August 2017

1 reference

Sayaka Nakashima

1

1 reference

18 August 2017

Shinichi Ota

2

1 reference

18 August 2017

Shin Arai

3

1 reference

18 August 2017

Kiyoko Yoshino

4

1 reference

18 August 2017

Mie Inao

5

1 reference

18 August 2017

Keiko Ishikawa

6

1 reference

18 August 2017

Nobuaki Nakayama

7

1 reference

18 August 2017

Yukinori Imai

8

1 reference

18 August 2017

Sumiko Nagoshi

9

1 reference

18 August 2017

Satoshi Mochida

10

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

World Journal of Gastroenterology

18 August 2017

1 reference

18 August 2017

15

1 reference

18 August 2017

6

1 reference

18 August 2017

727-731

1 reference

A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653442

Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653442

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653442

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653442

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653442

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653442

A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653442

A statistical evaluation on the age and sex distribution of basal serum gastrin and gastric acid secretion in subjects with or without peptic ulcer disease

20 October 2018

1 reference

12 December 2020

Comparison of Gastric Acid Secretion Rates and Serum Pepsin ogen I and II Concentrations in Occidental and Oriental Duodenal Ulcer Patients

1 reference

12 December 2020

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.15.727

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19222098

1 reference